This inventor holds 5 USPTO granted patents and 1 published patent application, plus 1 CIPO patent. Top assignees: Barnes Jewish Hospital, The Jewish Hospital of St. Louis, Washington University. Active years: 1991-2006.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- St. Louis, MO (US) (1991 - 2002)
- Cambridge, MA (US) (1998 - 2006)
Company Filing History:
3 out of 36 
1 out of 7 
1 out of 1,381 
Years Active: 1991-2006
Title: Thomas F Deuel: Innovating in Biomedical Research
Introduction:
Thomas F Deuel, a renowned inventor based in St. Louis, MO, has made significant contributions to the field of biomedical research. With five patents to his name, his work has focused on cutting-edge technologies aimed at treating and preventing abnormal cell growth states.
Latest Patents:
One of his latest patents includes the modulation of pleiotrophin signaling by receptor-type protein tyrosine phosphatase β/ζ (RPTP β/ζ), revealing the mechanism by which pleiotrophin binds to the receptor protein tyrosine phosphatase. This invention offers novel methods to modulate pleiotrophin expression and signaling for the treatment and prevention of abnormal cell growth, including inhibiting tumor growth, promotion, metastasis, invasiveness, and angiogenesis.
Another notable patent is related to DNA encoding heparin-binding growth factor, showcasing Deuel's expertise in genetic engineering and therapeutic molecule development.
Career Highlights:
With a background in working at prestigious institutions such as Barnes Jewish Hospital and Washington University, Thomas F Deuel has honed his skills in biotechnology and medical research. His innovative approach to problem-solving has led to groundbreaking discoveries in the field of molecular biology.
Collaborations:
Throughout his career, Deuel has collaborated with esteemed colleagues such as Zhao-Yi Wang and Thomas E Shenk. These partnerships have been instrumental in driving forward innovative research projects and bringing novel inventions to fruition.
Conclusion:
In conclusion, Thomas F Deuel stands out as a pioneering inventor in the realm of biomedical research. His patents reflect a deep understanding of cellular signaling pathways and a commitment to developing novel therapies for challenging medical conditions. Deuel's collaborations and career milestones underscore his dedication to advancing the frontiers of innovation in biotechnology.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile